{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:51:04Z","timestamp":1775836264929,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00103-019-02964-4","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T13:02:33Z","timestamp":1559566953000},"page":"818-824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fortschritte in der Cannabis-Forschung aus pharmazeutisch-chemischer Sicht","Progress in cannabis research from a\u00a0pharmaceutical chemist\u2019s point of view"],"prefix":"10.1007","volume":"62","author":[{"given":"Christa E.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"2964_CR1","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1002\/jcp.27725","volume":"234","author":"S Pisanti","year":"2019","unstructured":"Pisanti S, Bifulco M (2019) Medical cannabis: a\u00a0plurimillennial history of an evergreen. J\u00a0Cell Physiol 234:8342\u20138351","journal-title":"J Cell Physiol"},{"key":"2964_CR2","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1021\/acschemneuro.8b00651","volume":"10","author":"SD Banister","year":"2019","unstructured":"Banister SD, Arnold JC, Connor M, Glass M, McGregor IS (2019) Dark classics in chemical neuroscience: delta(9)-Tetrahydrocannabinol. ACS Chem Neurosci 10:2160\u20132173","journal-title":"ACS Chem Neurosci"},{"key":"2964_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG, Howlett AC, Abood ME et\u00a0al (2010) International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588\u2013631","journal-title":"Pharmacol Rev"},{"key":"2964_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nature23272","volume":"547","author":"T Hua","year":"2017","unstructured":"Hua T, Vemuri K, Nikas SP et al (2017) Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547:468\u2013471","journal-title":"Nature"},{"key":"2964_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cell.2018.11.040","volume":"176","author":"KK Kumar","year":"2019","unstructured":"Kumar KK, Shalev-Benami M, Robertson MJ et al (2019) Structure of a\u00a0signaling Cannabinoid receptor 1\u2011G protein complex. Cell 176:448\u2013458.e412","journal-title":"Cell"},{"key":"2964_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","volume":"176","author":"X Li","year":"2019","unstructured":"Li X, Hua T, Vemuri K et\u00a0al (2019) Crystal structure of the human Cannabinoid receptor CB2. Cell 176:459\u2013467.e413","journal-title":"Cell"},{"key":"2964_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","volume":"12","author":"C Ibeas Bih","year":"2015","unstructured":"Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ (2015) Molecular targets of Cannabidiol in neurological disorders. Neurotherapeutics 12:699\u2013730","journal-title":"Neurotherapeutics"},{"key":"2964_CR8","doi-asserted-by":"publisher","first-page":"32255","DOI":"10.1038\/srep32255","volume":"6","author":"C Flegel","year":"2016","unstructured":"Flegel C, Vogel F, Hofreuter A et al (2016) Characterization of non-olfactory GPCRs in human sperm with a\u00a0focus on GPR18. Sci Rep 6:32255","journal-title":"Sci Rep"},{"key":"2964_CR9","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.7717\/peerj.1835","volume":"4","author":"DB Finlay","year":"2016","unstructured":"Finlay DB, Joseph WR, Grimsey NL, Glass M (2016) GPR18 undergoes a\u00a0high degree of constitutive trafficking but is unresponsive to N\u2011Arachidonoyl Glycine. PeerJ 4:e1835","journal-title":"PeerJ"},{"key":"2964_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20150225","volume":"212","author":"N Chiang","year":"2015","unstructured":"Chiang N, Dalli J, Colas RA, Serhan CN (2015) Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J\u00a0Exp Med 212:1203\u20131217","journal-title":"J Exp Med"},{"key":"2964_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/cpt.1381","volume":"105","author":"K Cohen","year":"2019","unstructured":"Cohen K, Weizman A, Weinstein A (2019) Positive and negative effects of cannabis and Cannabinoids on health. Clin Pharmacol Ther 105:1139\u20131147","journal-title":"Clin Pharmacol Ther"},{"key":"2964_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5740\/jaoacint.18-0208","volume":"102","author":"LE Klumpers","year":"2019","unstructured":"Klumpers LE, Thacker DL (2019) A brief background on cannabis: from plant to medical indications. AOAC 102:412\u2013420","journal-title":"AOAC"},{"key":"2964_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.fertnstert.2005.08.027","volume":"85","author":"LB Whan","year":"2006","unstructured":"Whan LB, West MC, McClure N, Lewis SE (2006) Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 85:653\u2013660","journal-title":"Fertil Steril"},{"key":"2964_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1377","author":"MO Krebs","year":"2019","unstructured":"Krebs MO, Kebir O, Jay TM (2019) Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. Eur J Pain. \n                    https:\/\/doi.org\/10.1002\/ejp.1377\n                    \n                   (in press)","journal-title":"Eur J Pain"},{"key":"2964_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.4500","author":"G Gobbi","year":"2019","unstructured":"Gobbi G, Atkin T, Zytynski T et al (2019) Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a\u00a0systematic review and meta-analysis. JAMA Psychiatry. \n                    https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.4500\n                    \n                   (in press)","journal-title":"JAMA Psychiatry"},{"key":"2964_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamapsychiatry.2018.0335","volume":"75","author":"JC Scott","year":"2018","unstructured":"Scott JC, Slomiak ST, Jones JD et al (2018) Association of cannabis with cognitive functioning in adolescents and young adults: a\u00a0systematic review and meta-analysis. JAMA Psychiatry 75:585\u2013595","journal-title":"JAMA Psychiatry"},{"key":"2964_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00406-019-00981-7","volume":"269","author":"C Gorey","year":"2019","unstructured":"Gorey C, Kuhns L, Smaragdi E et al (2019) Age-related differences in the impact of cannabis use on the brain and cognition: a\u00a0systematic review. Eur Arch Psychiatry Clin Neurosci 269:37\u201358","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2964_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nm.4311","volume":"23","author":"A Bilkei-Gorzo","year":"2017","unstructured":"Bilkei-Gorzo A, Albayram O, Draffehn A et al (2017) A chronic low dose of Delta(9)-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med 23:782\u2013787","journal-title":"Nat Med"},{"key":"2964_CR19","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S et al (2008) Beta-caryophyllene is a\u00a0dietary cannabinoid. Proc Nat Acad Sci USA 105:9099\u20139104","journal-title":"Proc Nat Acad Sci USA"},{"key":"2964_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/ml300235q","volume":"4","author":"V Rempel","year":"2013","unstructured":"Rempel V, Fuchs A, Hinz S et\u00a0al (2013) Magnolia extract, Magnolol, and metabolites: activation of Cannabinoid CB2 receptors and blockade of the related GPR55. Acs Med Chem Lett 4:41\u201345","journal-title":"Acs Med Chem Lett"},{"key":"2964_CR21","doi-asserted-by":"publisher","first-page":"e77739","DOI":"10.1371\/journal.pone.0077739","volume":"8","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Rempel V, M\u00fcller CE (2013) The natural product magnolol as a\u00a0lead structure for the development of potent cannabinoid receptor agonists. PLoS ONE 8:e77739","journal-title":"PLoS ONE"},{"key":"2964_CR22","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1021\/jm3008213","volume":"55","author":"V Rempel","year":"2012","unstructured":"Rempel V, Volz N, Hinz S (2012) 7\u2011Alkyl-3-benzylcoumarins: a\u00a0versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists. J\u00a0Med Chem 55:7967\u20137977","journal-title":"J Med Chem"},{"key":"2964_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11419-016-0320-2","volume":"34","author":"C Hess","year":"2016","unstructured":"Hess C, Schoeder CT, Pillaiyar T, Madea B, M\u00fcller CE (2016) Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol 34:329\u2013343","journal-title":"Forensic Toxicol"},{"key":"2964_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/FBP.0000000000000323","volume":"28","author":"N Pintori","year":"2017","unstructured":"Pintori N, Loi B, Mereu M (2017) Synthetic cannabinoids: the hidden side of spice drugs. Behav Pharmacol 28:409\u2013419","journal-title":"Behav Pharmacol"},{"key":"2964_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/dta.2237","volume":"10","author":"V Angerer","year":"2018","unstructured":"Angerer V, Mogler L, Steitz JP et al (2018) Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE. Drug Test Anal 10:597\u2013603","journal-title":"Drug Test Anal"},{"key":"2964_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11419-018-0415-z","volume":"36","author":"CT Schoeder","year":"2018","unstructured":"Schoeder CT, Hess C, Madea B, Meiler J, M\u00fcller CE (2018) Pharmacological evaluation of new constituents of \u201cSpice\u201d: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds. Forensic Toxicol 36:385\u2013403","journal-title":"Forensic Toxicol"},{"key":"2964_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa1610300","volume":"376","author":"AJ Adams","year":"2017","unstructured":"Adams AJ, Banister SD, Irizarry L, Trecki J, Schwartz M, Gerona R (2017) \u201cZombie\u201d outbreak caused by the synthetic Cannabinoid AMB-FUBINACA in new York. N\u00a0Engl J Med 376:235\u2013242","journal-title":"N Engl J Med"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-02964-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-019-02964-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-02964-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T01:09:35Z","timestamp":1591060175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-019-02964-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2964"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-02964-4","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"3 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.E.\u00a0M\u00fcller gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}